{"nct_id":"NCT00045942","title":"PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome (CPKC412A2104 Core); and PKC412 in Participants With Acute Myeloid Leukemia or With Myelodysplastic Syndrome With Either Wild Type or Mutated FMS-like Tyrosine Kinase 3 (FLT3) (CPKC412A2104E1 and CPKC412A2104E2)","status":"COMPLETED","status_verified_date":"2017-08","start_date":"2002-01-30","start_date_type":"ACTUAL","primary_completion_date":"2008-03-27","primary_completion_date_type":"ACTUAL","completion_date":"2008-03-27","completion_date_type":"ACTUAL","phases":["PHASE1","PHASE2"],"tickers":["NVS"]}